Skip to content
Medalta
Biomie® Daily Premium
Daily wellness

Biomie® Daily Premium

Biomie® Daily Premium is daily care for your microbiome and natural immunity. It stabilises the intestinal microbiome, supports the immune response and contributes to healthy digestion.

Ten lacto- and bifidobacteria strains and an oligofructose prebiotic are protected inside a capsule that resists the acid environment of the stomach. One capsule a day is all it takes.

Per capsule — lacto- and bifidobacteria blend 20 billion CFU (300 mg): L. plantarum LLP-2L, L. plantarum LLP-4B, L. rhamnosus LLR-L1, L. casei LLC-4K, L. fermentum LLF-01, L. gasseri LLG-V74, L. bulgaricus LLB-05, B. bifidum LBB-02, B. longum LBL-01, B. lactis LBL-03. Oligofructose (prebiotic) 50 mg. Anti-caking agents: magnesium stearate, silicon dioxide.

One capsule daily, for example with breakfast. Swallow whole with enough water. Recommended for at least 3 months; suitable for long-term use.

Biomie® Daily Premium is a food supplement, not a medicine: it does not replace one and is not intended to diagnose, treat, cure or prevent any disease. Store in the original packaging in a dry place below 25 °C, away from sunlight, moisture and heat. No refrigeration needed. Not suitable for children under 6 or people with lactose intolerance.

About the product

Interesting information about Daily Premium

Ten strains, one daily capsule

Daily Premium combines ten characterised lacto- and bifidobacteria strains with an oligofructose prebiotic that feeds them — a complete synbiotic for everyday use.

Twenty billion live cultures (CFU) are protected inside a capsule that resists the acid environment of the stomach.

Why the gut comes first

More than 70% of immune cells are concentrated in the digestive tract, so a stable microbiome is the foundation of natural immunity and healthy digestion.

01 10 characterised strains
02 20 billion CFU per capsule
03 Oligofructose prebiotic
04 Acid-resistant capsule
Certifications & compliance

Ready for any regulator.

GMP Certified

GMP Certified

ISO Certified

ISO Certified

HACCP Certified

HACCP Certified

8 markets

8 markets

Why Medalta

What's doing the work.

10 strains

Lacto- & bifidobacteria

20 billion CFU

Per single capsule

Prebiotic

Oligofructose 50 mg

Acid-resistant

Protected through the stomach

Process

What's in one dose.

A four-stage development pipeline shared across every Medalta product line.

01 Lacto- & bifidobacteria blend
20 billion CFU · 300 mg

Ten characterised strains of Lactobacillus and Bifidobacterium selected for everyday digestion and immunity.

02 Oligofructose (prebiotic)
50 mg

A prebiotic fibre that selectively feeds the strains, supporting colonisation and microbiome diversity.

03 Capsule
1 capsule

Resists the acid environment of the stomach, so the cultures reach the intestine.

*CFU — colony-forming units, guaranteed through shelf life.

Not suitable for people with lactose intolerance.

Biomie® Daily Premium
FAQ

Questions, answered honestly.

All Questions

Most people notice initial changes within two to four weeks of daily use, but meaningful shifts in the microbiome take longer to establish. Daily Premium is formulated for continuous use — we recommend at least three months, and it is suitable for ongoing long-term use.

No — Biomie® Daily Premium is not suitable for people with lactose intolerance. If lactose is the issue rather than the strains themselves, ask us about alternatives in the range.

No refrigeration is needed. Keep the capsules in their original packaging in a dry place below 25°C, away from sunlight, moisture and heat — potency is guaranteed at room temperature through shelf life.

The capsule is acid-resistant, so the ten characterised strains and the twenty billion live cultures (CFU) inside it survive the stomach and reach the intestine, where they can actually colonise, instead of being broken down before they get there.

For partners

Build a microbiome programme with us.

Medalta partners with distributors, clinics and brands on white-label microbiome lines, regional registration and clinical co-development.

Start a conversation